Statistiche di base
| CIK | 1552845 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Natur International Corp.
SEC Filings (Chronological Order)
Questa pagina fornisce un elenco completo e cronologico dei depositi SEC, esclusi i documenti di proprietà che forniamo altrove.
| May 14, 2020 |
15-12G 1 ea121762-1512gnaturinter.htm FORM 15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0617 Expires: May 31, 2021 Estimated average burden hours per response . . . . . 1.50 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER |
|
| May 13, 2020 |
Natur International Corp. Parnassus Tower Locatellikade 1 1076 AZ Amsterdam The Netherlands May 13, 2020 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010 Re: Natur International Corp. Request to Withdraw Registration Statement on Form S-1 Effective Date: November 1, 2019 File No. 333-233929 Ladies and Gentlemen: Pursuant to Rule 477 |
|
| May 13, 2020 |
Natur International Corp. Parnassus Tower Locatellikade 1 1076 AZ Amsterdam The Netherlands May 13, 2020 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010 Re: Natur International Corp. Request to Withdraw Registration Statement on Form S-1 Effective Date: January 31, 2019 (by operation of law during government closure) File No. 333-22 |
|
| May 8, 2020 |
8-K/A 1 ea121588-8ka1naturinter.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2020 Natur International Corp. (Exact name of registrant as specified in its charter) Wyoming 000-5491 |
|
| May 8, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2020 Natur International Corp. (Exact name of registrant as specified in its charter) Wyoming 000-54917 45-5547692 (State or other jurisdiction of incorporation) (Commission |
|
| May 1, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2020 Natur International Corp. (Exact name of registrant as specified in its charter) Wyoming 000-54917 45-5547692 (State or other jurisdiction of incorporation) (Commission |
|
| March 20, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2020 Natur International Corp. (Exact name of registrant as specified in its charter) Wyoming 000-54917 45-5547692 (State or other jurisdiction of incorporation) (Commission |
|
| March 13, 2020 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 13, 2020 Natur International Corp. (Exact name of registrant as specified in its charter) Wyoming 000-54917 45-5547692 (State or other jurisdiction of incorporation) (Commission |
|
| March 13, 2020 |
Exhibit 99.1 Shenzhen Yihaitong Technology Co., Ltd. Dear Ruud: As you know we have been enduring the consequences of the COVID 19 virus which has raged and spread throughout China. Our Chong Qing operations are being handled as best as possible but not in office rather we have ultimately and recently created a virtual working environment. The fact is we have not been able to use our office facili |
|
| February 20, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* NATUR INTERNATIONAL CORP. (FORMERLY FUTURE HEALTHCARE OF AMERICA) (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 36117F100 (CUSIP Number) Tommaso Mingazzini, Ph.D. GFG Monaco SAM 74 Boulevard d’Italie, 98000 Mona |
|
| January 14, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2020 Natur International Corp. (Exact name of registrant as specified in its charter) Wyoming 000-54917 45-5547692 (State or other jurisdiction of incorporation) (Commissio |
|
| December 16, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 13, 2019 Natur International Corp. (Exact name of registrant as specified in its charter) Wyoming 000-54917 45-5547692 (State or other jurisdiction of incorporation) (Commis |
|
| November 27, 2019 |
natuR INTERNATIONAL CORP. 235,579,089 Shares Common Stock Filed Pursuant to Rule 424(b)(4) Registration Statement 333-233929 PROSPECTUS natuR INTERNATIONAL CORP. |
|
| November 27, 2019 |
natuR INTERNATIONAL CORP. 200,000,000 Shares Common Stock Filed Pursuant to Rule 424(b)(4) Registration Statement 333-233929 PROSPECTUS natuR INTERNATIONAL CORP. |
|
| November 15, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 25, 2019 Natur International Corp. (Exact name of registrant as specified in its charter) Wyoming 000-54917 45-5547692 (State or other jurisdiction of incorporation) (Commis |
|
| November 15, 2019 |
NTRU / Natur International Corp. NT 10-Q - - NOTIFICATION OF LATE FILING NT 10-Q 1 extf10q0919naturinternation.htm NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING OMB APPROVAL OMB Number: 3235-0058 Expires: February 28, 2022 Estimated average burden hours per response ............ 2.50 SEC FILE NUMBER 0001552845 CUSIP NUMBER 63883U103 (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form |
|
| November 15, 2019 |
Amendment to the Company’s Bylaws effective November 7, 2019 EX-3.1 2 f8k092519ex3-1naturinter.htm AMENDMENT TO THE COMPANY'S BYLAWS EFFECTIVE NOVEMBER 7, 2019 Exhibit 3.1 Article III, Section 2, of the Company’s Bylaws is amended to read in its entirety as follows: Section 2. Number and Term in Office. This Section 2 is subject to the provisions in a formal certificate of rights, powers and designations relating to the rights of the holders of one or more |
|
| November 15, 2019 |
Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-54917 NATUR INTERNATIONAL CO |
|
| November 5, 2019 |
natuR INTERNATIONAL CORP. 200,000,000 Shares Common Stock Filed Pursuant to Rule 424(b)(4) Registration Statement 333-233929 PROSPECTUS natuR INTERNATIONAL CORP. |
|
| November 5, 2019 |
natuR INTERNATIONAL CORP. 235,579,089 Shares Common Stock Filed Pursuant to Rule 424(b)(4) Registration Statement 333-233929 PROSPECTUS natuR INTERNATIONAL CORP. |
|
| October 30, 2019 |
NTRU / Natur International Corp. CORRESP - - Natur International Corp. Jachthavenweg 124 1081 KJ Amsterdam The Netherlands October 30, 2019 Securities and Exchange Commission 100 F. Street, N.E. Washington, D.C. 20549 Re: Natur International Corp. Registration Statement on Form S-1 File No. 333-233929 Ladies and Gentlemen: In connection with the above referenced Registration Statement on Form S-1 of Natur International Corp., the undersigned |
|
| October 29, 2019 |
NTRU / Natur International Corp. S-1/A - - AMENDMENT NO. 1 TO FORM S-1 As filed with the Securities and Exchange Commission on October 29, 2019 Registration No. |
|
| October 29, 2019 |
NTRU / Natur International Corp. CORRESP - - Golenbock Eiseman Assor Bell & Peskoe LLP 711 Third Avenue, 17th Floor New York, New York 10017 (212) 212-907-7300 October 29, 2019 Securities and Exchange Commission 100 F Street N. |
|
| October 17, 2019 |
Articles of Amendment to the Restated Articles of Incorporation of Registrant (F Preferred) (15) EX-3.3 4 f8k101619ex3-3naturinter.htm CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF THE REGISTRANT FOR THE SERIES F PREFERRED STOCK Exhibit 3.3 2 3 4 5 6 7 8 9 10 |
|
| October 17, 2019 |
Articles of Amendment to the Restated Articles of Incorporation of Registrant (E Preferred) (15) EX-3.2 3 f8k101619ex3-2naturinter.htm CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF THE REGISTRANT FOR THE SERIES E PREFERRED STOCK Exhibit 3.2 2 3 4 5 6 7 |
|
| October 17, 2019 |
Articles of Amendment to the Restated Articles of Incorporation of Registrant (G Preferred) (15) EX-3.4 5 f8k101619ex3-4naturinter.htm CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION OF THE REGISTRANT FOR THE SERIES G PREFERRED STOCK Exhibit 3.4 2 3 4 5 6 7 |
|
| October 17, 2019 |
Articles of Amendment to the Restated Articles of Incorporation of Registrant (D Preferred) (15) Exhibit 3.1 2 3 4 5 6 7 |
|
| October 17, 2019 |
Material Modification to Rights of Security Holders, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 16, 2019 Natur International Corp. (Exact name of registrant as specified in its charter) Wyoming 000-54917 45-5547692 (State or other jurisdiction of incorporation) (Commissi |
|
| September 25, 2019 |
NTRU / Natur International Corp. S-1 - Registration Statement - REGISTRATION STATEMENT As filed with the Securities and Exchange Commission on September 25, 2019 Registration No. |
|
| September 25, 2019 |
List of Subsidiaries – Direct and Indirect Exhibit 21.1 List of Subsidiaries – Direct and Indirect Name Jurisdiction Percentage Owned Natur BPS B.V. The Netherlands 100 % Future Healthcare Services Nevada 100 % Interim Healthcare of Wyoming, Inc. Wyoming 100 % NL Juices Retail BV The Netherlands 100 % NL Juices Online BV The Netherlands 100 % NFF Trading BV The Netherlands 100 % Naturalicious Rest of Europe BV The Netherlands 100 % Hi tech |
|
| September 12, 2019 |
Service Agreement for Boaz Wachtel (14) EX-10.1 2 f8k090619bex10-01natur.htm AGREEMENT TO RENDER INDEPENDENT BOARD MEMBER SERVICES BETWEEN BOAZ WACHTEL AND NATUR INTERNATIONAL CORP., DATED SEPTEMBER 6, 2019 Exhibit 10.01 Agreement to render independent board member services between Mr. Boaz Wachtel, with a registered address (P.o.B 3577) herein after referred to as (BW) #11 Alon St, Kfar Netter 40593 Israel and (Natur International Corp |
|
| September 12, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 6, 2019 Natur International Corp. (Exact name of registrant as specified in its charter) Wyoming 000-54917 45-5547692 (State or other jurisdiction of incorporation) (Commiss |
|
| September 11, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A#1 CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 29, 2019 Natur International Corp. (Exact name of registrant as specified in its charter) Wyoming 000-54917 45-5547692 (State or other jurisdiction of incorporation) (Commi |
|
| September 11, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 29, 2019 Natur International Corp. (Exact name of registrant as specified in its charter) Wyoming 000-54917 45-5547692 (State or other jurisdiction of incorporation) (Commissio |
|
| September 3, 2019 |
Service Agreement for Mark Simmonds (Mortlock Securities Ltd) (13) EX-10.1 2 f8k082019ex10-1naturinter.htm EMPLOYMENT ARRANGEMENTS BETWEEN MORTLOCK SECURITIES LTD. AND THE REGISTRANT REGARDING MARK SIMMONDS DATED AUGUST 2019 Exhibit 10.1 Agreement to render independent board member services between Mortlock Securities Ltd, represented by Mr. M. Simmonds, a private company with limited liability incorporated under the laws of the United Kingdom and with a register |
|
| September 3, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 20, 2019 Natur International Corp. (Exact name of registrant as specified in its charter) Wyoming 000-54917 45-5547692 (State or other jurisdiction of incorporation) (Commissio |
|
| August 14, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-54917 NATUR INTERNATIONAL CORP. ( |
|
| August 13, 2019 |
NTRU / Natur International Corp. / Nl Life Sciences Bv - SCHEDULE 13D Activist Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13D-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13D-2(a) Natur International Corp. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 63883U 103 (CUSIP Number) Andrew D. Hudders, Esq. Golenbock Eiseman Ass |
|
| July 31, 2019 |
Warrant Agreement initially issued to DRBG Holdco, LLC, as of July 24, 2019 EX-10.2 3 f8k072519ex10-2naturinter.htm WARRANT AGREEMENT INITIALLY ISSUED TO DRBG HOLDCO, LLC, AS OF JULY 24, 2019 Exhibit 10.2 FORM OF WARRANT THIS WARRANT AND ANY SECURITIES ACQUIRED UPON THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR FOREIGN JURISDICTION. NEIT |
|
| July 31, 2019 |
Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 25, 2019 Natur International Corp. (Exact name of registrant as specified in its charter) Wyoming 000-54917 45-5547692 (State or other jurisdiction of incorporation) (Commission |
|
| July 31, 2019 |
EX-99.1 4 f8k072519ex99-1naturinter.htm PRESS RELEASE DATED JULY 31, 2019, ANNOUNCING THE PURCHASE OF TEMPLE TURMERIC, INC. BY NATUR INTERNATIONAL CORP. Exhibit 99.1 IMMEDIATE RELEASE Natur International Acquires Controlling Interest in U.S.-based Temple Turmeric Beverages Share Natur, a Eurasian functional product company, adds the wellness of turmeric-based beverages offered by Temple, as platfo |
|
| July 31, 2019 |
Purchase and Recapitalization Agreement, dated as of July 24, 2019 EX-10.1 2 f8k072519ex10-1naturinter.htm PURCHASE AND RECAPITALIZATION AGREEMENT, DATED AS OF JULY 24, 2019 Exhibit 10.1 PURCHASE AND RECAPITALIZATION AGREEMENT This Purchase and Recapitalization Agreement, dated as of July 24, 2019 (this “Agreement”), is entered into by and among Natur International Corp., a Wyoming corporation (“Natur”), DRBG Holdco, LLC, a Delaware limited liability company (“DR |
|
| July 25, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 19, 2019 Natur International Corp. (Exact name of registrant as specified in its charter) Wyoming 000-54917 45-5547692 (State or other jurisdiction of incorporation) (Commission |
|
| July 1, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 25, 2019 Natur International Corp. (Exact name of registrant as specified in its charter) Wyoming 000-54917 45-5547692 (State or other jurisdiction of incorporation) (Commission |
|
| June 27, 2019 |
Articles of Amendment to the Restated Articles of Incorporation of Registrant (8) EX-3.1 2 f8k062619ex3-1naturintl.htm AMENDMENT TO THE CERTIFICATE OF INCORPORATION, DATED JUNE 26, 2019, TO INCREASE THE CAPITALIZATION OF THE REGISTRANT TO $750,000,000 SHARES OF COMMON STOCK AND 5,000,000 SHARES OF PREFERRED STOCK Exhibit 3.1 |
|
| June 27, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 26, 2019 Natur International Corp. (Exact name of registrant as specified in its charter) Wyoming 000-54917 45-5547692 (State or other jurisdiction of incorporation) (Commission |
|
| May 28, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2019 Natur International Corp. (Exact name of registrant as specified in its charter) Wyoming 000-54917 45-5547692 (State or other jurisdiction of incorporation) (Commission F |
|
| May 15, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-54917 NATUR INTERNATIONAL CORP. |
|
| April 16, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-54917 Natur Internat |
|
| April 10, 2019 |
Debt Conversion and Extinguishment Agreement EX-10.1 3 f8k040919ex10-1natur.htm DEBT CONVERSION AND EXTINGUISHMENT AGREEMENT Exhibit 10.1 Debt Conversion and Extinguishment Agreement Reference is made to that certain original Debt Agreement made as of December 21, 2017 and the amendment made to that agreement at June 11, 2018 (the “Debt Agreement”) by and between Natur Holding B.V., a company formed under the laws of the Netherlands (the “Co |
|
| April 10, 2019 |
Articles of Amendment to the Restated Articles of Incorporation of Registrant (7) EX-3.1 2 f8k040919ex3-1natur.htm ARTICLES OF AMENDMENT Exhibit 3.1 ARTICLES OF AMENDMENT OF NATUR INTERNATIONAL INC PURSUANT TO SECTIONs 17-16-1006, 17-16-1005 and 17-16-602 OF THE wyoming Business Corporation Act The undersigned, Robert Paladino and Ellen Berkers, do hereby certify that: 1. They are the Chief Executive Officer and Chief Financial Officer, respectively, of Natur International Inc. |
|
| April 10, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 9, 2019 Natur International Corp. (Exact name of registrant as specified in its charter) Wyoming 000-54917 45-5547692 (State or other jurisdiction of incorporation) (Commission |
|
| March 28, 2019 |
NTRU / Natur International Corp. NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54917 (Check One): xForm 10-K ¨Form 20-F ¨Form 11-K ¨ Form 10-Q ¨Form 10-D ¨Form N-SAR ¨Form N-CSR For Period Ended: December 31, 2018 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition |
|
| March 4, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20509 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 1, 2019 Date of Report (Date of earliest event reported) NATUR INTERNATIONAL CORP. (Exact name of registrant as specified in its charter) WYOMING 000-54917 45-5547692 (State or other jurisdiction of incorporation or organizatio |
|
| February 26, 2019 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2019 Natur International Corp. (Exact name of registrant as specified in its charter) Wyoming 000-54917 45-5547692 (State or other jurisdiction of incorporation) (Commiss |
|
| February 22, 2019 |
NTRU / Natur International Corp. AMENDMENT NO. 1 TO DEFA14C SCHEDULE 14C/A (Rule 14c-101) INFORMATION REQUIRED IN INFORMATION STATEMENT SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information Statement ☒ Definitive Additional Materials NATUR INTERNATIONAL CORP. |
|
| February 19, 2019 |
NTRU / Natur International Corp. DEFINITIVE ADDITIONAL MATERIALS SCHEDULE 14C (Rule 14c-101) INFORMATION REQUIRED IN INFORMATION STATEMENT SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information Statement ☒ Definitive Additional Materials NATUR INTERNATIONAL CORP. |
|
| February 19, 2019 |
NTRU / Natur International Corp. DEFINITIVE INFORMATION STATEMENT SCHEDULE 14C (Rule 14c-101) INFORMATION REQUIRED IN INFORMATION STATEMENT SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☒ Definitive Information Statement NATUR INTERNATIONAL CORP. |
|
| February 8, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2019 Natur International Corp. (Exact name of registrant as specified in its charter) Wyoming 000-54917 45-5547692 (State or other jurisdiction of incorporation) (Commissi |
|
| February 7, 2019 |
NTRU / Natur International Corp. PRELIMINARY INFORMATION STATEMENT SCHEDULE 14C (Rule 14c-101) INFORMATION REQUIRED IN INFORMATION STATEMENT SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, For Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information Statement NATUR INTERNATIONAL CORP. |
|
| February 4, 2019 |
natuR INTERNATIONAL CORP. 120,481,405 Shares Common Stock Filed Pursuant to Rule 424(b)(4) Registration Statement 333-229201 PROSPECTUS natuR INTERNATIONAL CORP. |
|
| January 29, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1) NATUR INTERNATIONAL CORP. f/k/a FUTURE HEALTHCARE OF AMERICA (Name of Issuer) COMMON STOCK (Title of Class of Securities) 63883U103 (CUSIP Number) December 31, 2018 (DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT) Check the appropriate box to desig |
|
| January 23, 2019 |
EX-99.1 2 f8k011619ex99-1naturinter.htm PRESS RELEASE DATED JANUARY 23, 2019, ANNOUNCING NEW BOARD MEMBERS Exhibit 99.1 IMMEDIATE RELEASE Natur International Corp. Appoints Bay, Huisman and Storms to an Expanding Board of Directors Natur, Europe's technology-inspired innovative healthy food and beverage company, attracts entrepreneurial, financial and technical savvy to its Board of Directors Amst |
|
| January 23, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20509 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 16, 2019 Date of Report (Date of earliest event reported) NATUR INTERNATIONAL CORP. (Exact name of registrant as specified in its charter) WYOMING 000-54917 45-5547692 (State or other jurisdiction of incorporation or organiza |
|
| January 11, 2019 |
List of Subsidiaries, Ownership and Location of Incorporation (12) EX-21.1 7 fs12019ex21-1naturinter.htm SUBSIDIARIES Exhibit 21.1 List of Subsidiaries – Direct and Indirect Name Jurisdiction Percentage Owned Natur Holding BV The Netherlands 100 % Future Healcare Services Nevada 100 % Inerim Healthcare of Wyoming, Inc. Wyoming 100 % Subsidiaries held by Natur Holding BV NL Juices Retail BV The Netherlands 100 % NL Juices Online BV The Netherlands 100 % NFF Tradin |
|
| January 11, 2019 |
Warrant, dated October 13, 2018, issued to Alpha Capital Anstalt (33,000,000 Shares) (9) EX-4.1 2 fs12019ex4-1naturinter.htm WARRANT, DATED OCTOBER 13, 2018, ISSUED TO ALPHA CAPITAL ANSTALT (33,000,000 SHARES) Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933 |
|
| January 11, 2019 |
FUTU / Future Healthcare of America REGISTRATION STATEMENT As filed with the Commission on January 11, 2019 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 NATUR INTERNATIONAL CORP. (Exact name of registrant as specified in its charter) Wyoming 2037 45-5547692 (State or other jurisdiction of incorporation or organization) (Primary Standard Indust |
|
| January 11, 2019 |
Indemnification Agreement – Christopher Spencer (12) EX-10.5 6 fs12019ex10-5naturinter.htm INDEMNIFICATION AGREEMENT - CHRISTOPHER SPENCER Exhibit 10.5 INDEMNITY AGREEMENT This Indemnity Agreement (the “Agreement”), effective as of October 18, 2018, is made by and between Future Healthcare of America, a Wyoming corporation (the “Company”), and Christopher J. Spencer, a director and/or consultant to the Company and the former CEO of the Company (the |
|
| January 11, 2019 |
Warrant, dated November 13, 2018, issued to Alpha Capital Anstalt (6,000,000 Shares) (10) Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR |
|
| January 11, 2019 |
Distribution Agreement with Leen Menken Food Service Logistics (11) Exhibit 10.4 Processor agreement The undersigned: (1) NFF Trading BV, having its registered office and registered office at Jachthavenweg 124, Amsterdam, hereby legally represented by I. Siemes in the position of Director, hereinafter referred to as “NL juice online B.V.” or “Responsible”; And (2) Leen Menken Foodservice Logistics B.V., having its registered office and registered office in Zoeterm |
|
| January 11, 2019 |
Financial Statements and Exhibits 8-K/A 1 f8k111318a2futurehealth.htm AMENDMENT NO. 2 TO CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20509 FORM 8-K / AMENDMENT NO. 2 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 13, 2018 Date of Report (Date of earliest event reported) FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as specified in its cha |
|
| January 10, 2019 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20509 FORM 8-K / AMENDMENT NO. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 13, 2018 Date of Report (Date of earliest event reported) FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as specified in its charter) WYOMING 000-54917 45-5547692 (State or other jurisdiction of inc |
|
| January 4, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 28, 2018 Natur International Corp. (Exact name of registrant as specified in its charter) Wyoming 000-54917 45-5547692 (State or other jurisdiction of incorporation) (Commiss |
|
| January 4, 2019 |
Articles of Amendment to the Restated Articles of Incorporation of Registrant (6) Exhibit 3.1 |
|
| December 11, 2018 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant 8-K 1 futu8k121118.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20509 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 10, 2018 Date of Report (Date of earliest event reported) FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as specified in its charter) WYOMING 000-54917 45-5547692 (State or other jurisdicti |
|
| December 11, 2018 |
Letter from Sadler, Gibb & Associates, LLC EX-16 2 exhibit161.htm EXHIBIT 16.1 Exhibit 16.1 |
|
| November 19, 2018 |
8-K 1 futu8k111918.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20509 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 13, 2018 Date of Report (Date of earliest event reported) FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as specified in its charter) WYOMING 000-54917 45-5547692 (State or other jurisdicti |
|
| November 19, 2018 |
EX-99 3 exhibit991.htm EXHIBIT 99.1 Exhibit 99.1 Future Healthcare of America Completes Share Exchange Transaction of Natur Holding Europe's first hi-tech health food and beverage company Natur is set to revolutionize the Natural juice and snack market Amsterdam, The Netherlands, November 15, 2018 - Future Healthcare of America, (OTC: FUTU) (the “Company”) today announced the consummation of its s |
|
| November 19, 2018 |
Exhibit 10.3 REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of September 21, 2018, between Future Healthcare of America, a Wyoming corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”). This Agreement is made pursuant to the Securities |
|
| November 15, 2018 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20509 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 13, 2018 Date of Report (Date of earliest event reported) FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as specified in its charter) WYOMING 000-54917 45-5547692 (State or other jurisdiction of incorporation or orga |
|
| November 15, 2018 |
Future Healthcare of America Completes Share Exchange Transaction of Natur Holding EX-99 2 exhibit991.htm EXHIBIT 99.1 Exhibit 99.1 Future Healthcare of America Completes Share Exchange Transaction of Natur Holding Amsterdam, The Netherlands - Future Healthcare of America (the “Company”) announced the consummation of its share exchange transaction with Natur Holding B.V., a Netherlands-based company (“Natur”) as of November 13, 2018. Natur is Europe's first hi-tech health food a |
|
| November 9, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q/A1 [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-54917 FUTURE HEALTHCA |
|
| November 2, 2018 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder PROSPECTUS SUPPLEMENT NO. 22 TO PROSPECTUS DATED DECEMBER 12, 2013 FILED PURSUANT TO RULE 424(b)(3) REGISTRATION STATEMENT NO. 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This Prospectus Supplement No. 22 supplements our Prospectus dated December 12, 2013 (the “Prospectus”) that forms a part of our first amended Registration Statement on |
|
| November 2, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-54917 FUTURE HEALTHCARE |
|
| October 23, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20509 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 18, 2018 Date of Report (Date of earliest event reported) FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as specified in its charter) WYOMING 000-54917 45-5547692 (State or other jurisdiction of incorporation or organ |
|
| October 23, 2018 |
Second Amended and Restated Articles of Incorporation of the Registrant (1) SECOND AMENDED AND RESTATED ARTICLES OF INCORPORATION OF FUTURE HEALTHCARE OF AMERICA The undersigned, Christopher J. |
|
| October 3, 2018 |
AMENDED AND RESTATED ARTICLES OF INCORPORATION FUTURE HEALTHCARE OF AMERICA AMENDED AND RESTATED ARTICLES OF INCORPORATION OF FUTURE HEALTHCARE OF AMERICA The undersigned, Christopher J. |
|
| October 3, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20509 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 28, 2018 Date of Report (Date of earliest event reported) FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as specified in its charter) WYOMING 000-54917 45-5547692 (State or other jurisdiction of incorporation or org |
|
| September 24, 2018 |
SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of September 21, 2018, between Future Healthcare of America, a Wyoming corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”). |
|
| September 24, 2018 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 f8kdraft2btbredline92418.htm CURRENT REPORT ON FORM 8-K DATED SEPTEMBER 21, 2018 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20509 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 21, 2018 Date of Report (Date of earliest event reported) FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as specified in its cha |
|
| September 24, 2018 |
SHARE EXCHANGE AGREEMENT by and among FUTURE HEALTHCARE OF AMERICA NATUR HOLDING B. |
|
| August 31, 2018 |
Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20509 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 31, 2018 Date of Report (Date of earliest event reported) FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as specified in its charter) WYOMING 000-54917 45-5547692 (State or other jurisdiction of incorporation or organi |
|
| August 10, 2018 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder U PROSPECTUS SUPPLEMENT NO. 21 TO PROSPECTUS DATED DECEMBER 12, 2013 FILED PURSUANT TO RULE 424(b)(3) REGISTRATIO |
|
| August 10, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-54917 FUTURE HEALTHCARE OF AM |
|
| July 18, 2018 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant Converted by EDGARwiz UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 16, 2018 FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as specified in its charter) WYOMING 000-54917 45-5547692 (State or other jurisdiction (Commission File Number) (I. |
|
| July 18, 2018 |
4397 SOUTH ALBRIGHT DRIVE • SALT LAKE CITY, UTAH 84124 Converted by EDGARwiz 4397 SOUTH ALBRIGHT DRIVE • SALT LAKE CITY, UTAH 84124 (801) 277-2763 PHONE • (801) 277-6509 FAX July 16, 2018 U. |
|
| May 21, 2018 |
8-K 1 f8kdraft6btbclean52118.htm CURRENT REPORT ON FORM 8-K DATED MAY 18, 2018 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20509 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 18, 2018 Date of Report (Date of earliest event reported) FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as specified in its charter) WYOMING |
|
| May 4, 2018 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder PROSPECTUS SUPPLEMENT NO. 20 TO PROSPECTUS DATED DECEMBER 12, 2013 FILED PURSUANT TO RULE 424(b)(3) REGISTRATION STATEMENT NO. 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This Prospectus Supplement No. 20 supplements our Prospectus dated December 12, 2013 (the “Prospectus”) that forms a part of our first amended Registration Statement on |
|
| May 4, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-54917 FUTURE HEALTHCARE OF A |
|
| March 28, 2018 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder PROSPECTUS SUPPLEMENT NO. 19 TO PROSPECTUS DATED DECEMBER 12, 2013 FILED PURSUANT TO RULE 424(b)(3) REGISTRATION STATEMENT NO. 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This Prospectus Supplement No. 19 supplements our Prospectus dated December 12, 2013 (the “Prospectus”) that forms a part of our first amended Registration Statement on |
|
| March 28, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 000-54917 FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as spe |
|
| December 20, 2017 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder 424B3 1 f424b3.htm 424B3 PROSPECTUS SUPPLEMENT NO. 18 TO PROSPECTUS DATED DECEMBER 12, 2013 FILED PURSUANT TO RULE 424(b)(3) REGISTRATION STATEMENT NO. 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This Prospectus Supplement No. 18 supplements our Prospectus dated December 12, 2013 (the “Prospectus”) that forms a part of our first amended R |
|
| December 20, 2017 |
8-K 1 form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20509 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 14, 2017 Date of Report (Date of earliest event reported) FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as specified in its charter) WYOMING 000-54917 45-5547692 (State or other jurisdictio |
|
| November 9, 2017 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder U PROSPECTUS SUPPLEMENT NO. 17 TO PROSPECTUS DATED DECEMBER 12, 2013 FILED PURSUANT TO RULE 424(b)(3) REGISTRATION STATEMENT NO. 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This Prospectus Supplement No. 17 supplements our Prospectus dated December 12, 2013 (the ?Prospectus?) that forms a part of our first amended Registration Statement o |
|
| November 9, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-54917 FUTURE HEALTHCARE |
|
| August 11, 2017 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder U PROSPECTUS SUPPLEMENT NO. 16 TO PROSPECTUS DATED DECEMBER 12, 2013 FILED PURSUANT TO RULE 424(b)(3) REGISTRATION STATEMENT NO. 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This Prospectus Supplement No. 16 supplements our Prospectus dated December 12, 2013 (the ?Prospectus?) that forms a part of our first amended Registration Statement o |
|
| August 11, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-54917 FUTURE HEALTHCARE OF AM |
|
| May 12, 2017 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder U PROSPECTUS SUPPLEMENT NO. 15 TO PROSPECTUS DATED DECEMBER 12, 2013 FILED PURSUANT TO RULE 424(b)(3) REGISTRATION STATEMENT NO. 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This Prospectus Supplement No. 15 supplements our Prospectus dated December 12, 2013 (the ?Prospectus?) that forms a part of our first amended Registration Statement o |
|
| May 12, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-54917 FUTURE HEALTHCARE OF A |
|
| March 24, 2017 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder UNITED STATES PROSPECTUS SUPPLEMENT NO. 14 TO PROSPECTUS DATED DECEMBER 12, 2013 FILED PURSUANT TO RULE 424(b)(3) REGISTRATION STATEMENT NO. 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This Prospectus Supplement No. 14 supplements our Prospectus dated December 12, 2013 (the ?Prospectus?) that forms a part of our first amended Registration |
|
| March 24, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 000-54917 FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as spe |
|
| November 10, 2016 |
2,976,980 Shares of Common Stock Offered by Selling Stockholder U PROSPECTUS SUPPLEMENT NO. 13 TO PROSPECTUS DATED DECEMBER 12, 2013 FILED PURSUANT TO RULE 424(b)(3) REGISTRATION STATEMENT NO. 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This Prospectus Supplement No. 13 supplements our Prospectus dated December 12, 2013 (the ?Prospectus?) that forms a part of our first amended Registration Statement o |
|
| November 10, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-54917 FUTURE HEALTHCARE |
|
| August 5, 2016 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder U PROSPECTUS SUPPLEMENT NO. 12 TO PROSPECTUS DATED DECEMBER 12, 2013 FILED PURSUANT TO RULE 424(b)(3) REGISTRATION STATEMENT NO. 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This Prospectus Supplement No. 12 supplements our Prospectus dated December 12, 2013 (the ?Prospectus?) that forms a part of our first amended Registration Statement o |
|
| August 5, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-54917 FUTURE HEALTHCARE OF AM |
|
| May 2, 2016 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder U PROSPECTUS SUPPLEMENT NO. 11 TO PROSPECTUS DATED DECEMBER 12, 2013 FILED PURSUANT TO RULE 424(b)(3) REGISTRATION STATEMENT NO. 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This Prospectus Supplement No. 11 supplements our Prospectus dated December 12, 2013 (the ?Prospectus?) that forms a part of our first amended Registration Statement o |
|
| May 2, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-54917 FUTURE HEALTHCARE OF A |
|
| March 11, 2016 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder UNITED STATES PROSPECTUS SUPPLEMENT NO. 10 TO PROSPECTUS DATED DECEMBER 12, 2013 FILED PURSUANT TO RULE 424(b)(3) REGISTRATION STATEMENT NO. 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This Prospectus Supplement No. 10 supplements our Prospectus dated December 12, 2013 (the ?Prospectus?) that forms a part of our first amended Registration |
|
| March 11, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 000-54917 FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as spe |
|
| November 5, 2015 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder 424B3 1 supplementno911515.htm PROSPECTUS SUPPLEMENT NO. 9 PROSPECTUS SUPPLEMENT NO. 9 TO PROSPECTUS DATED DECEMBER 12, 2013 FILED PURSUANT TO RULE 424(b)(3) REGISTRATION STATEMENT NO. 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This Prospectus Supplement No. 9 supplements our Prospectus dated December 12, 2013 (the “Prospectus”) that for |
|
| November 5, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-54917 FUTURE HEALTHCARE |
|
| October 13, 2015 |
Termination of a Material Definitive Agreement United States Securities and Exchange Commission Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15[d] of the Securities Exchange Act of 1934 October 6, 2015 Date of Report FUTURE HEALTHCARE OF AMERICA. (Exact name of Registrant as specified in its Charter) Wyoming 000-54917 45-5547692 (State or Other Jurisdiction of (Commission File Number) (I.R.S. Employer Identification |
|
| September 11, 2015 |
FUTU / Future Healthcare of America / ALPHA CAPITAL ANSTALT - SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) FUTURE HEALTHCARE OF AMERICA (Name of Issuer) COMMON STOCK (Title of Class of Securities) 36117F100 (CUSIP Number) September 10, 2015 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which |
|
| September 8, 2015 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits United States Securities and Exchange Commission Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15[d] of the Securities Exchange Act of 1934 September 4, 2015 Date of Report FUTURE HEALTHCARE OF AMERICA. (Exact name of Registrant as specified in its Charter) Wyoming 000-54917 45-5547692 (State or Other Jurisdiction of (Commission File Number) (I.R.S. Employer Identificati |
|
| September 8, 2015 |
EX-10 2 mergeragreementbtbdraft12cle.htm MERGER AND SHARE EXCHANGE AGREEMENT MERGER AND SHARE EXCHANGE AGREEMENT dated September 4, 2015 by and among Future Healthcare of America, a Wyoming corporation, as the Parent, F3 Acquisition Subsidiary, Inc., a California corporation, as the Acquisition Subsidiary, F3 & Associates, Inc., a California corporation, as the Company MERGER AND SHARE EXCHANGE AG |
|
| August 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q/A1 10-Q/A 1 f10qfinal63014.htm AMENDED QUARTERLY REPORT ON FORM 10Q/A FOR THE QUARTER ENDED JUNE 30, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q/A1 [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EX |
|
| August 14, 2015 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder UNITED STATES FIRST AMENDED PROSPECTUS SUPPLEMENT NO. 1 TO PROSPECTUS DATED DECEMBER 12, 2013 FILED PURSUANT TO RULE 424(b)(3) REGISTRATION STATEMENT NO. 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This first amended Prospectus Supplement No. 1 supplements our Prospectus dated December 12, 2013 (the ?Prospectus?) that forms a part of our |
|
| August 14, 2015 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder 424B3 1 supplementno881415.htm PROSPECTUS SUPPLEMENT NO. 8 PROSPECTUS SUPPLEMENT NO. 8 TO PROSPECTUS DATED DECEMBER 12, 2013 FILED PURSUANT TO RULE 424(b)(3) REGISTRATION STATEMENT NO. 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This Prospectus Supplement No. 8 supplements our Prospectus dated December 12, 2013 (the “Prospectus”) that for |
|
| August 14, 2015 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder U FIRST AMENDED PROSPECTUS SUPPLEMENT NO. 3 TO PROSPECTUS DATED DECEMBER 12, 2013 FILED PURSUANT TO RULE 424(b)(3) REGISTRATION STATEMENT NO. 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This first amended Prospectus Supplement No. 3 supplements our Prospectus dated December 12, 2013 (the Prospectus) that forms a part of our first amende |
|
| August 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q/A1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q/A1 [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-54917 FUTURE HEALTHCARE O |
|
| August 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q/A1 10-Q/A 1 f10q315final.htm AMENDED QUARTERLY REPORT ON FORM 10Q/A FOR THE QUARTER ENDED MARCH 31, 2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q/A1 [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EX |
|
| August 14, 2015 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder UNITED STATES FIRST AMENDED PROSPECTUS SUPPLEMENT NO. 5 TO PROSPECTUS DATED DECEMBER 12, 2013 FILED PURSUANT TO RULE 424(b)(3) REGISTRATION STATEMENT NO. 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This first amended Prospectus Supplement No. 5 supplements our Prospectus dated December 12, 2013 (the ?Prospectus?) that forms a part of our |
|
| August 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K/A1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K/A1 [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 000-54917 FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as |
|
| August 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q 10-Q 1 f10qq22015final.htm QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED JUNE 30, 2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF |
|
| August 14, 2015 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder FIRST AMENDED PROSPECTUS SUPPLEMENT NO. 4 TO PROSPECTUS DATED DECEMBER 12, 2013 FILED PURSUANT TO RULE 424(b)(3) REGISTRATION STATEMENT NO. 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This first amended Prospectus Supplement No. 4 supplements our Prospectus dated December 12, 2013 (the Prospectus) that forms a part of our first amended |
|
| August 14, 2015 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder U FIRST AMENDED PROSPECTUS SUPPLEMENT NO. 6 TO PROSPECTUS DATED DECEMBER 12, 2013 FILED PURSUANT TO RULE 424(b)(3) REGISTRATION STATEMENT NO. 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This first amended Prospectus Supplement No. 6 supplements our Prospectus dated December 12, 2013 (the Prospectus) that forms a part of our first amende |
|
| August 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q/A1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q/A1 [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-54917 FUTURE HEALTHCA |
|
| August 14, 2015 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder U FIRST AMENDED PROSPECTUS SUPPLEMENT NO. 2 TO PROSPECTUS DATED DECEMBER 12, 2013 FILED PURSUANT TO RULE 424(b)(3) REGISTRATION STATEMENT NO. 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This first amended Prospectus Supplement No. 2 supplements our Prospectus dated December 12, 2013 (the ?Prospectus?) that forms a part of our first amende |
|
| August 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q/A1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q/A1 [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-54917 FUTURE HEALTHCA |
|
| August 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K/A1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K/A1 [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 000-54917 FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as |
|
| August 11, 2015 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder United States Securities and Exchange Commission PROSPECTUS SUPPLEMENT NO. 7 TO PROSPECTUS DATED DECEMBER 12, 2013 FILED PURSUANT TO RULE 424(b)(3) REGISTRATION STATEMENT NO. 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This Prospectus Supplement No. 7 supplements our Prospectus dated December 12, 2013 (the ?Prospectus?) that forms a part |
|
| August 11, 2015 |
United States Securities and Exchange Commission Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 10, 2015 Date of Report FUTURE HEALTHCARE OF AMERICA (Exact name of Registrant as specified in its Charter) Wyoming 000-54917 45-5547692 (State or Other Jurisdiction of (Commission File Number) (I.R.S. Employer Identification |
|
| June 23, 2015 |
EX-99 2 pressreleasefhaf3loi62215fi.htm PRESS RELEASE DATED JUNE 22, 2015 Future Healthcare of America Signs Term Sheet To Acquire Leader in Industrial Asset Intelligence Transaction to Spin-Off Current Healthcare Business to FHA Shareholders PALM BEACH, FL - June 22, 2015 – Future Healthcare of America (OTCQB: FUTU; “FHA” or the “Company”) today announced that it has signed a non-binding letter o |
|
| June 23, 2015 |
Regulation FD Disclosure, Financial Statements and Exhibits United States Securities and Exchange Commission Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 22, 2015 FUTURE HEALTHCARE OF AMERICA (Exact name of Registrant as specified in its Charter) Wyoming 000-54917 45-5547692 (State or Other Jurisdiction of (Commission File Number) |
|
| June 22, 2015 |
8-K 1 f8kfhaf3mergerloiv3edgardra.htm 8-K CURRENT REPORT DATED JUNE 18, 2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20509 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 18, 2015 Date of Report (Date of earliest event reported) FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as specified in its charter) WYOMING 0 |
|
| May 11, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-54917 FUTURE HEALTHCARE OF A |
|
| May 11, 2015 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder U PROSPECTUS SUPPLEMENT NO. 6 FILED PURSUANT TO RULE 424(b)(3) TO PROSPECTUS DATED REGISTRATION STATEMENT NO. DECEMBER 12, 2013 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This Prospectus Supplement No. 6 supplements our Prospectus dated December 12, 2013 (the ?Prospectus?) that forms a part of our first amended Registration Statement on |
|
| February 6, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K 10-K 1 f10kv2clean.htm ANNUAL REPORT ON FORM 10K FOR THE YEAR ENDED DECEMBER 31, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commi |
|
| February 6, 2015 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder PROSPECTUS SUPPLEMENT NO. 5 FILED PURSUANT TO RULE 424(b)(3) TO PROSPECTUS DATED REGISTRATION STATEMENT NO. DECEMBER 12, 2013 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This Prospectus Supplement No. 5 supplements our Prospectus dated December 12, 2013 (the “Prospectus”) that forms a part of our first amended Registration Statement on Fo |
|
| November 5, 2014 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder FILED PURSUANT TO RULE 424(b)(3) TO PROSPECTUS DATED REGISTRATION STATEMENT NO. DECEMBER 12, 2013 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This Prospectus Supplement No. 4 supplements our Prospectus dated December 12, 2013 (the “Prospectus”) that forms a part of our first amended Registration Statement on Form S-1 (Securities and Excha |
|
| November 5, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-54917 FUTURE HEALTHCARE |
|
| August 7, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-54917 FUTURE HEALTHCARE OF AM |
|
| August 7, 2014 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder PROSPECTUS SUPPLEMENT NO. 3 FILED PURSUANT TO RULE 424(b)(3) TO PROSPECTUS DATED REGISTRATION STATEMENT NO. DECEMBER 12, 2013 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This Prospectus Supplement No. 3 supplements our Prospectus dated December 12, 2013 (the “Prospectus”) that forms a part of our first amended Registration Statement on Fo |
|
| May 9, 2014 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder PROSPECTUS SUPPLEMENT NO. 2 FILED PURSUANT TO RULE 424(b)(3) TO PROSPECTUS DATED REGISTRATION STATEMENT NO. DECEMBER 12, 2013 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This Prospectus Supplement No. 2 supplements our Prospectus dated December 12, 2013 (the “Prospectus”) that forms a part of our first amended Registration Statement on Fo |
|
| May 9, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-54917 FUTURE HEALTHCARE OF A |
|
| March 20, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 000-54917 FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as spe |
|
| March 20, 2014 |
FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder PROSPECTUS SUPPLEMENT NO. 1 FILED PURSUANT TO RULE 424(b)(3) TO PROSPECTUS DATED REGISTRATION STATEMENT NO. DECEMBER 12, 2013 333-191622 FUTURE HEALTHCARE OF AMERICA 2,976,980 Shares of Common Stock Offered by Selling Stockholder This Prospectus Supplement No. 1 supplements our Prospectus dated December 12, 2013 (the “Prospectus”) that forms a part of our first amended Registration Statement on Fo |
|
| January 30, 2014 | ||
| January 30, 2014 |
Financial Statements and Exhibits, Other Events 8-K 1 f8kclean13014chriscommnets.htm CURRENT REPORT ON FORM 8-K DATED JANUARY 14, 2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20509 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 14, 2014 Date of Report (Date of earliest event reported) FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as specified in its chart |
|
| January 30, 2014 |
Converted by EDGARwiz |
|
| December 12, 2013 |
Filed pursuant to Rule 424(b)(4) Registration No. 333-191622 PROSPECTUS Prospectus $ 744,245 December 12, 2013 2,976,980 Shares of Common Stock Offered by Selling Stockholder This prospectus covers an aggregate of 2,976,980 shares of our common stock that the selling stockholder may sell. Our common stock is quoted on the OTC Bulletin Board of FINRA under the symbol "FUTU." On November 13 , 2013, |
|
| December 9, 2013 |
FUTURE HEALTHCARE OF AMERICA FUTURE HEALTHCARE OF AMERICA 5001 BAUM BOULEVARD, SUITE 770 PITTSBURGH, PENNSYLVANIA 15213 December 9, 2013 John Reynolds, Assistant Director U. |
|
| December 2, 2013 |
FUTURE HEALTHCARE OF AMERICA 5001 BAUM BOULEVARD, SUITE 770 PITTSBURGH, PENNSYLVANIA 15213 December 2, 2013 Securities and Exchange Commission Division of Corporation Finance 100 F Street N. |
|
| November 14, 2013 |
Converted by EDGARwiz SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of August 30, 2013, between Future Healthcare of America, a Wyoming corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”). |
|
| November 14, 2013 |
COMMON STOCK PURCHASE WARRANT FUTURE HEALTHCARE OF AMERICA EXHIBIT C NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRAT |
|
| November 14, 2013 |
EXTENSION AND WAIVER AGREEMENT EXTENSION AND WAIVER AGREEMENT THIS EXTENSION AND WAIVER AGREEMENT (the “Agreement”), dated as of November 13, 2013, is entered into by and among Future Healthcare of America, a Wyoming corporation (the “Company”), and the person identified as the “Holder” on the signature page hereto (the “Holder”). |
|
| November 14, 2013 |
EXHIBIT E SECURITY AGREEMENT This SECURITY AGREEMENT, dated as of August 30, 2013 (this “Agreement”), is among Future Healthcare of America, a Wyoming corporation (the “Company”), all of the Subsidiaries of the Company (such subsidiaries , the “ Guarantors ” and together with the Company , the “Debtors”) and the holders of the Company’s Variable Rate Senior Secured Convertible Debentures due 18 months following their issuance, in the original aggregate principal amount of $1,010,000 (collectively, the “Debentures”) signatory hereto, their endorsees, transferees and assigns (collectively, the “Secured Parties”). |
|
| November 14, 2013 |
ARTICLES OF INCORPORATION FUTURE HEALTHCARE OF AMERICA ARTICLES OF INCORPORATION OF FUTURE HEALTHCARE OF AMERICA Pursuant to Section 17-16-202 of the Wyoming Business Corporation Act (the “WBCA”), the undersigned incorporator does hereby adopt and make the following Articles of Incorporation: ARTICLE I - NAME The name of the corporation (hereinafter called the “Corporation”) is “Future Healthcare of America. |
|
| November 14, 2013 |
EXTENSION AND WAIVER AGREEMENT EXTENSION AND WAIVER AGREEMENT THIS EXTENSION AND WAIVER AGREEMENT (the “Agreement”), dated as of November 13, 2013, is entered into by and among Future Healthcare of America, a Wyoming corporation (the “Company”), and the person identified as the “Holder” on the signature page hereto (the “Holder”). |
|
| November 14, 2013 |
VARIABLE RATE SENIOR SECURED CONVERTIBLE DEBENTURE DUE _____, 2015 EXHIBIT A NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRA |
|
| November 14, 2013 |
EXHIBIT B REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of August 30, 2013, between Future Healthcare of America, a Wyoming corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”). |
|
| November 14, 2013 |
- FIRST AMENDMENT TO OUR S-1 REGISTRATION STATEMENT As filed with the Securities and Exchange Commission November 14, 2013 Registration No. |
|
| November 14, 2013 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 f8k111313final.htm CURRENT REPORT ON FORM 8-K DATED NOVEMBER 13, 2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20509 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 13, 2013 Date of Report (Date of earliest event reported) FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as specified in its charter) WYOMIN |
|
| November 14, 2013 |
FUTURE HEALTHCARE OF AMERICA 5001 BAUM BOULEVARD, SUITE 770 PITTSBURGH, PENNSYLVANIA 15213 November 14, 2013 Securities and Exchange Commission Division of Corporation Finance 100 F Street N. |
|
| November 14, 2013 |
BYLAWS FUTURE HEALTHCARE OF AMERICA (hereinafter called the "Corporation") ARTICLE I EX-3 4 bylaws2.htm BYLAWS BYLAWS OF FUTURE HEALTHCARE OF AMERICA (hereinafter called the "Corporation") ARTICLE I OFFICES Section 1. Registered Office. The registered office of the Corporation shall be in the State of Wyoming. Section 2. Other Offices. The Corporation may also have offices at such other places both within and without the State of Wyoming as the Board of Directors may from time to |
|
| November 14, 2013 |
EXHIBIT F SUBSIDIARY GUARANTEE SUBSIDIARY GUARANTEE, dated as of August 30, 2013 (this “Guarantee”), made by each of the signatories hereto (together with any other entity that may become a party hereto as provided herein, the “Guarantors”), in favor of the purchasers signatory (together with their permitted assigns, the “Purchasers”) to that certain Securities Purchase Agreement, dated as of the date hereof, between Future Healthcare of America, a Wyoming corporation (the “Company”) and the Purchasers. |
|
| November 14, 2013 |
Code of Business Conduct and Ethics Code of Business Conduct and Ethics This Code of Business Conduct and Ethics (the Code) sets forth legal and ethical standards of conduct for directors, officers and employees of Future Healthcare of America and its subsidiaries (the Company). |
|
| November 8, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-54917 FUTURE HEALTHCARE |
|
| October 8, 2013 |
Registration Statement - S-1 REGISTRATION STATEMENT As filed with the Securities and Exchange Commission October 1, 2013 Registration No. |
|
| September 4, 2013 |
EX-10 6 futuspafinal.htm SECURITIES PURCHASE AGREEMENT SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of August 30, 2013, between Future Healthcare of America, a Wyoming corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers |
|
| September 4, 2013 |
EX-10 4 futusubsidguaranteefinal.htm SUBSIDAIRY GUARANTEE EXHIBIT F SUBSIDIARY GUARANTEE SUBSIDIARY GUARANTEE, dated as of August 30, 2013 (this “Guarantee”), made by each of the signatories hereto (together with any other entity that may become a party hereto as provided herein, the “Guarantors”), in favor of the purchasers signatory (together with their permitted assigns, the “Purchasers”) to th |
|
| September 4, 2013 |
VARIABLE RATE SENIOR SECURED CONVERTIBLE DEBENTURE DUE _____, 2015 EX-10 2 futudebenturefinal1.htm FORM OF VARIABLE RATE SENIOR SECURED CONVERTIBLE DEBENTURE EXHIBIT A NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES A |
|
| September 4, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20509 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 30, 2013 Date of Report (Date of earliest event reported) FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as specified in its charter) WYOMING 000-54917 45-5547692 (State or other jurisdiction of incorporation or organi |
|
| September 4, 2013 |
EX-10 7 futurrafinal.htm REGISTRATION RIGHTS AGREEMENT EXHIBIT B REGISTRATION RIGHTS AGREEMENT This Registration Rights Agreement (this “Agreement”) is made and entered into as of August 30, 2013, between Future Healthcare of America, a Wyoming corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”). |
|
| September 4, 2013 |
EX-10 3 futusafinal.htm SECURITY AGREEMENT EXHIBIT E SECURITY AGREEMENT This SECURITY AGREEMENT, dated as of August 30, 2013 (this “Agreement”), is among Future Healthcare of America, a Wyoming corporation (the “Company”), all of the Subsidiaries of the Company (such subsidiaries , the “ Guarantors ” and together with the Company , the “Debtors”) and the holders of the Company’s Variable Rate Seni |
|
| September 4, 2013 |
COMMON STOCK PURCHASE WARRANT FUTURE HEALTHCARE OF AMERICA EX-10 5 futuwarrantfinal1.htm FORM OF WARRANT EXHIBIT C NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR |
|
| August 1, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q 10-Q 1 f10q613final.htm QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED JUNE 30, 2013 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 193 |
|
| May 3, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-54917 FUTURE HEALTHCARE OF A |
|
| March 29, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 333-182338 FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as sp |
|
| March 29, 2013 |
Code of Business Conduct and Ethics Code of Business Conduct and Ethics This Code of Business Conduct and Ethics (the Code) sets forth legal and ethical standards of conduct for directors, officers and employees of Future Healthcare of America and its subsidiaries (the Company). |
|
| March 22, 2013 |
FUTU / Future Healthcare of America / SPENCER CHRISTOPHER J - SCHEDULE 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 FUTURE HEALTHCARE OF AMERICA (Name of Issuer) Common Voting Stock (Title of Class of Securities) 36117F 100 (CUSIP Number) March 21, 2013 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ |
|
| March 21, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 FUTURE HEALTHCARE OF AMERICA (Exact name of registrant as specified in its charter) WYOMING 45-5547692 (State of incorporation or organization) (I.R.S. Employer Identification No.) 5001 Baum Blvd. |
|
| November 30, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 333-183636 FUTURE HEALTHCARE |
|
| November 21, 2012 |
FUTURE HEALTHCARE OF AMERICA Supplement No. 1 Prospectus dated August 30, 2012 PROSPECTUS SUPPLEMENT NO. 1 Filed pursuant to Rule 424(b)(3) TO PROSPECTUS DATED AUGUST 30, 2012 Registration No. 333-183636 FUTURE HEALTHCARE OF AMERICA Supplement No. 1 to Prospectus dated August 30, 2012 This Prospectus Supplement no. 1 supplements and amends our Prospectus, dated August 30, 2012. This Prospectus Supplement No. 1 should be read in conjunction with, and may not be delivered or u |
|
| August 31, 2012 |
Filed pursuant to Rule 424(b)(4) Registration No. 333-183636 Prospectus $244.03 August 30, 2012 10,162,310 SHARES OF COMMON STOCK, PAR VALUE $0.001 PER SHARE OF FUTURE HEALTHCARE OF AMERICA BEING SPUN-OFF BY ITS PARENT, WIZZARD SOFTWARE CORPORATION (“WZE”) 10,162,310 shares of common stock, par value $0.001 per share (the “Shares”) of Future Healthcare of America (“FHA” or the “Registrant” or “we, |
|
| August 31, 2012 |
- AMENDED S1 REGISTRATION STATEMENT As filed with the Securities and Exchange Commission August 30, 2012 Registration No. |
|
| August 30, 2012 |
FUTURE HEALTHCARE OF AMERICA FUTURE HEALTHCARE OF AMERICA 5001 BAUM BLVD., SUITE 770 PITTSBURGH, PENNSYLVANIA 15213 August 30, 2012 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Re: Future Healthcare of America, a Wyoming corporation (the “Company”) Post-effective amendment to Registration Statement on Form S-1, filed on August 30, 2012 (the “Amendment”) Commission Fil |
|
| August 30, 2012 |
Filed pursuant to Rule 424(b)(4) Registration No. 333-182338 Prospectus $244.03 August 30, 2012 10,162,310 SHARES OF COMMON STOCK, PAR VALUE $0.001 PER SHARE OF FUTURE HEALTHCARE OF AMERICA BEING SPUN-OFF BY ITS PARENT, WIZZARD SOFTWARE CORPORATION (“WZE”) 10,162,310 shares of common stock, par value $0.001 per share (the “Shares”) of Future Healthcare of America (“FHA” or the “Registrant” or “we, |
|
| August 30, 2012 |
As filed with the Securities and Exchange Commission August 30, 2012 Registration No. |
|
| August 23, 2012 |
Filed pursuant to Rule 424(b)(4) Registration No. 333-182338 Prospectus $244.03 August 23, 2012 10,112,310 SHARES OF COMMON STOCK, PAR VALUE $0.001 PER SHARE OF FUTURE HEALTHCARE OF AMERICA BEING SPUN-OFF BY ITS PARENT, WIZZARD SOFTWARE CORPORATION (“WZE”) 10,112,310 shares of common stock, par value $0.001 per share (the “Shares”) of Future Healthcare of America (“FHA” or the “Registrant” or “we, |
|
| August 20, 2012 |
FUTURE HEALTHCARE OF AMERICA 5001 Baum Boulevard, Suite 770 Pittsburgh, Pennsylvania 15213 August 20, 2012 John Reynolds, Assistant Director U. |
|
| August 15, 2012 |
- S-1/A-2 REGISTRATION STATEMENT As filed with the Securities and Exchange Commission August 15, 2012 Registration No. |
|
| August 15, 2012 |
INTERIM HEALTHCARE® FULL SERVICE FRANCHISE AGREEMENT EX-10 9 billingsfranchiseagreement.htm INTERIM HEALTHCARE OF WYOMING FRANCHISE AGREEMENT (BILLINGS, MONTANA) INTERIM HEALTHCARE® FULL SERVICE FRANCHISE AGREEMENT AGREEMENT, made and entered into this day by and between INTERIM HEALTHCARE INC., a Florida corporation, hereinafter referred to as “Company,” and INTERIM HEALTHCARE OF WYOMING, INC., a Wyoming corporation, hereinafter referred to as “Fra |
|
| August 15, 2012 |
412. 621.0902 Tel 412. 621.2625 Fax www.wizzardsoftware.com 5001 Baum Blvd. Suite 770 Pittsburgh PA 15213 August 15, 2012 Securities and Exchange Commission Division of Corporation Finance Attn: John Reynolds 100 F Street N.E. Washington DC 20549 Re: Future Healthcare of America Amendment No. 1 to Registration Statement on Form S-1 Filed July 27, 2012 File No. 333-182338 Dear Mr. Reynolds: In resp |
|
| August 15, 2012 |
INTERIM SERVICES INC. FRANCHISE AGREEMENT EX-10 8 casperfranchiseagreement.htm INTERIM HEALTHCARE OF WYOMING FRANCHISE AGREEMENT (CASPER, WYOMING) INTERIM SERVICES INC. FRANCHISE AGREEMENT AGREEMENT, made and entered into this day by and between INTERIM SERVICES INC., a Delaware corporation, hereinafter referred to as "Company," and INTERIM HEALTHCARE OF WYOMIMNG, INC., a Wyoming corporation, hereinafter referred to as "Franchisee": W I T |
|
| July 27, 2012 |
INTERIM SERVICES INC. FRANCHISE AGREEMENT INTERIM SERVICES INC. FRANCHISE AGREEMENT AGREEMENT, made and entered into this day by and between INTERIM SERVICES INC., a Delaware corporation, hereinafter referred to as "Company," and INTERIM HEALTHCARE OF WYOMIMNG, INC., a Wyoming corporation, hereinafter referred to as "Franchisee": W I T N E S S E T H: WHEREAS, Company has developed and is the owner of certain plans, procedures and methods |
|
| July 27, 2012 |
- S-1/A-1 REGISTRATION STATEMENT As filed with the Securities and Exchange Commission April , 2012 Registration No As filed with the Securities and Exchange Commission July 27, 2012 Registration No. |
|
| July 27, 2012 |
INTERIM HEALTHCARE® FULL SERVICE FRANCHISE AGREEMENT INTERIM HEALTHCARE® FULL SERVICE FRANCHISE AGREEMENT AGREEMENT, made and entered into this day by and between INTERIM HEALTHCARE INC. |
|
| July 27, 2012 |
412. 621.0902 Tel 412. 621.2625 Fax www.wizzardsoftware.com 5001 Baum Blvd. Suite 770 Pittsburgh PA 15213 July 27, 2012 Securities and Exchange Commission Division of Corporation Finance Attn: John Reynolds 100 F Street N.E. Washington DC 20549 Re: Future Healthcare of America Registration Statement on Form S-1 Filed June 26 2012 File No. 333-182338 Dear Mr. Reynolds: In response to your letter of |
|
| June 26, 2012 |
SEPARATION AGREEMENT SEPARATION AGREEMENT BY AND BETWEEN WIZZARD SOFTWARE CORPORATION AND FUTURE HEALTHCARE OF AMERICA DATED AS OF June 22, 2012 Exhibits Exhibit I - Tax Matters Agreement SEPARATION AGREEMENT THIS SEPARATION AGREEMENT (the “Agreement”) is dated as of June 22, 2012, by and between Wizzard Software Corporation, a Colorado corporation (“WZE”), and Future Healthcare of America, a Wyoming corporation and wholly owned subsidiary of WZE (“FHA”). |
|
| June 26, 2012 |
Registration Statement - REGISTRATION STATEMENT ON FORM S-1 As filed with the Securities and Exchange Commission June 26, 2012 Registration No. |
|
| June 26, 2012 |
Articles of Amendment to the Restated Articles of Incorporation (name change) of Registrant (6) ARTICLES OF INCORPORATION OF FUTURE HEALTHCARE OF AMERICA Pursuant to Section 17-16-202 of the Wyoming Business Corporation Act (the “WBCA”), the undersigned incorporator does hereby adopt and make the following Articles of Incorporation: ARTICLE I - NAME The name of the corporation (hereinafter called the “Corporation”) is “Future Healthcare of America. |
|
| June 26, 2012 |
AMENDED AND RESTATED BYLAWS OF FUTURE HEALTHCARE OF AMERICA (hereinafter called the "Corporation") ARTICLE I OFFICES Section 1. |
|
| June 26, 2012 |
INTERIM SERVICES INC. FRANCHISE AGREEMENT INTERIM SERVICES INC. FRANCHISE AGREEMENT AGREEMENT, made and entered into this day by and between INTERIM SERVICES INC., a Delaware corporation, hereinafter referred to as "Company," and INTERIM HEALTHCARE OF WYOMIMNG, INC., a Wyoming corporation, hereinafter referred to as "Franchisee": W I T N E S S E T H: WHEREAS, Company has developed and is the owner of certain plans, procedures and methods |
|
| June 26, 2012 |
INTERIM HEALTHCARE® FULL SERVICE FRANCHISE AGREEMENT INTERIM HEALTHCARE® FULL SERVICE FRANCHISE AGREEMENT AGREEMENT, made and entered into this day by and between INTERIM HEALTHCARE INC. |
|
| June 26, 2012 |
TAX MATTERS AGREEMENT by and among WIZZARD SOFTWARE CORPORATION, and FUTURE HEALTHCARE OF AMERICA DATED AS OF June 22, 2012 TAX MATTERS AGREEMENT THIS TAX MATTERS AGREEMENT (this “Agreement”) dated as of June 22, 2012, by and between Wizzard Software Corporation, a Colorado corporation (“WZE”) and Future Healthcare of America, a Wyoming corporation (“FHA”), (collectively, the “Parties”) is entered into in connection with the Split-Off, as per the Separation Agreement, between the same Parties, of the same date, to which this Agreement is attached. |
